Predicting Mortality in Kidney Transplant Recipients
Launched by PARIS TRANSLATIONAL RESEARCH CENTER FOR ORGAN TRANSPLANTATION · Jul 31, 2024
Trial Information
Current as of June 26, 2025
Enrolling by invitation
Keywords
ClinConnect Summary
The number of individuals suffering from end-stage chronic renal disease (ESRD) worldwide has increased over time, exceeding seven million of patients in 2020. For individuals with ESRD, kidney transplantation is the best treatment in terms of patient survival, quality of life and from a cost-effective standpoint, as compared with dialysis, even in comorbid or elderly populations.
Although the number of kidney transplantations performed each year has increased as well, it follows a lower pace than the increase of individuals on the waiting-list, resulting in an organ shortage. There is the...
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Adult kidney recipients
- Exclusion Criteria:
- • Multi-organ transplantation
- • Prior kidney transplant
About Paris Translational Research Center For Organ Transplantation
The Paris Translational Research Center for Organ Transplantation is a leading clinical trial sponsor dedicated to advancing the field of organ transplantation through innovative research and collaborative efforts. Committed to bridging the gap between laboratory discoveries and clinical applications, the center focuses on improving transplant outcomes, enhancing patient care, and developing novel therapeutic strategies. With a multidisciplinary team of experts, the center fosters a rigorous research environment that promotes scientific excellence and ethical standards, ultimately aiming to transform the landscape of organ transplantation and provide hope for patients in need of lifesaving procedures.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Paris, , France
Paris, , France
Paris, , France
Phoenix, Arizona, United States
San Francisco, California, United States
Philadelphia, Pennsylvania, United States
Leuven, , Belgium
Liège, , Belgium
Toulouse, , France
Tours, , France
Leiden, , Netherlands
Patients applied
Trial Officials
Alexandre Loupy
Principal Investigator
Paris Institute for Transplantation and Organ Regeneration (PITOR)
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported